|
BK
|
Financial Services |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$96.7B
|
$77.41
|
-0.5%
|
-0.6%
|
+1.3%
|
+0.1%
|
-0.0%
|
-3.2%
|
|
IMO
|
Energy |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$69.4B
|
$62.52
|
-0.1%
|
-0.2%
|
+1.2%
|
+4.3%
|
+0.7%
|
+0.8%
|
|
VIST
|
Energy |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$8.5B
|
$55.90
|
+0.0%
|
-3.1%
|
+0.6%
|
+5.5%
|
-1.8%
|
+2.4%
|
|
POR
|
Utilities |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$5.5B
|
$43.21
|
-0.8%
|
-0.1%
|
-1.9%
|
+0.5%
|
+0.3%
|
-4.9%
|
|
RRR
|
Consumer Cyclical |
Jefferies |
Downgrade
|
Buy
→
Hold
|
—
|
$5.3B
|
$44.72
|
-1.7%
|
+0.4%
|
+1.1%
|
-1.3%
|
-1.9%
|
-1.7%
|
|
LAZ
|
Financial Services |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$4.8B
|
$50.74
|
-0.4%
|
-2.5%
|
+2.0%
|
-0.5%
|
-0.4%
|
-5.4%
|
|
IMVT
|
Healthcare |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$4.0B
|
$25.19
|
-2.7%
|
-1.5%
|
-0.7%
|
+0.0%
|
-4.1%
|
-0.6%
|
|
RNG
|
Technology |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
—
|
$3.7B
|
$34.83
|
-2.4%
|
+1.6%
|
+3.9%
|
-7.5%
|
-1.4%
|
-1.8%
|
|
ACAD
|
Healthcare |
Guggenheim |
Downgrade
|
Buy
→
Neutral
|
—
|
$3.6B
|
$18.66
|
-2.2%
|
-1.3%
|
-5.2%
|
-0.4%
|
+1.2%
|
-1.9%
|
|
VERX
|
Technology |
Raymond James |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$2.4B
|
$53.20
|
-1.3%
|
-3.5%
|
+1.2%
|
+0.7%
|
+1.2%
|
-1.5%
|
|
INTA
|
Technology |
Raymond James |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$1.6B
|
$64.63
|
-1.1%
|
-1.5%
|
-1.6%
|
-0.9%
|
+2.0%
|
+5.9%
|
|
TWFG
|
Financial Services |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$1.1B
|
$30.00
|
-2.8%
|
-1.0%
|
-3.9%
|
-1.3%
|
-3.7%
|
+6.3%
|
|
BMBL
|
Technology |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$328M
|
$7.97
|
-5.1%
|
+1.6%
|
+1.6%
|
-2.1%
|
-6.2%
|
+0.0%
|